PLK1 and breast carcinoma: WTS8 and Bliss assays demonstrated that lowering the basal PLK1 expression in the breast cancer cell lines through miR-183-5p-mediated regulation would make them more sensitive to NMS-P937, resulting in a synergistic increase in apoptosis.